Tuesday, July 4, 2023 Daily Archives

Donaldson expands portfolio with $148m Univercells buy

The acquisition of Univercells Technologies is a significant step in our strategy and expanding our product portfolio, says Donaldson Company. Minneapolis-based filtration firm Donaldson has bought Belgium-based Univercells for €136 million ($148 million) on a cash-free, debt-free basis and subject to closing agreements. Univercells provides biomanufacturing solutions for cell and gene therapy (CGT) research, advancement, and commercial production. In February 2020, global investment firm KKR – through its portfolio of life sciences tools companies Gamma Biosciences – committed €50 million ($54…

ARM says EU plans would take 90% of advanced therapies off the market

The Alliance for Regenerative Medicine (ARM) says 90% of advanced therapies on the market would have been rejected under proposed EU clinical assessment methods. The industry raised the concerns about the European Union (EU) joint clinical assessment (JCA) regulation in June, based on an assessment of 18 ATMPs that currently hold EU marketing authorization, including several cell and gene therapies (CGTs). According to the ARM the methodologies proposed by the EUnetHTA-21 consortium for consideration by the HTA Coordination Group would…